Lynn Seely is President, Chief Executive Officer and Director of Lyell Immunopharma, Inc. (LYEL). The company reported total compensation of $4,222,265 for fiscal year 2025.
| Salary | $690,173 |
|---|---|
| Bonus | $0 |
| Stock awards | $186,806 |
| Option awards | $2,907,551 |
| Non-equity incentive plan | $414,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $23,735 |
| Total | $4,222,265 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Lyell Immunopharma, Inc. filed April 24, 2026, accession 0001140361-26-016686.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $690,173 | $0 | $186,806 | $2,907,551 | $414,000 | $0 | $23,735 | $4,222,265 |
| FY2024 | President, Chief Executive Officer and Director | $675,962 | — | $474,000 | — | $324,000 | — | $21,414 | $1,495,376 |
Totals as disclosed in each year's own compensation disclosure for Lyell Immunopharma, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Lynn Seely this page | President, Chief Executive Officer and Director | $4,222,265 |
| Stephen Hill | Chief Operating Officer | $2,076,439 |
| Gary Lee | Chief Scientific Officer | $1,942,621 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Lyell Immunopharma, Inc. compensation brief.
Lynn Seely's compensation sits inside Lyell Immunopharma, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.